Literature DB >> 9687398

Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP.

Y Hirakata1, K Izumikawa, T Yamaguchi, H Takemura, H Tanaka, R Yoshida, J Matsuda, M Nakano, K Tomono, S Maesaki, M Kaku, Y Yamada, S Kamihira, S Kohno.   

Abstract

Gram-negative rods (GNR) carrying the transferable carbapenem resistance gene blaIMP, including Pseudomonas aeruginosa and Serratia marcescens, have been isolated from more than 20 hospitals in Japan. Although the emergence of such multiple-drug-resistant bacteria is of utmost clinical concern, little information in regard to the distribution of blaIMP-positive GNR in hospitals and the clinical characteristics of infected patients is available. To address this, a system for the rapid detection of the blaIMP gene with a simple DNA preparation and by enzymatic detection of PCR products was developed. A total of 933 ceftazidime-resistant strains of GNR isolated between 1991 and 1996 at Nagasaki University Hospital, Nagasaki, Japan, were screened for the blaIMP gene; 80 isolates were positive, including 53 P. aeruginosa isolates, 13 other glucose-nonfermenting bacteria, 13 S. marcescens isolates, and 1 Citrobacter freundii isolate. Most of the patients from whom blaIMP-positive organisms were isolated had malignant diseases (53. 8%). The organisms caused urinary tract infections, pneumonia, or other infections in 46.3% of the patients, while they were just colonizing the other patients evaluated. It was possible that blaIMP-positive P. aeruginosa strains contributed to the death of four patients, while the other infections caused by GNR carrying blaIMP were not lethal. DNA fingerprinting analysis by pulsed-field gel electrophoresis suggested the cross transmission of strains within the hospital. The isolates were ceftazidime resistant and were frequently resistant to other antibiotics. Although no particular means of pathogenesis of blaIMP-positive GNR is evident at present, the rapid detection of such strains is necessary to help with infection control practices for the prevention of their dissemination and the transmission of the resistance gene to other pathogenic bacteria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687398      PMCID: PMC105724     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636.

Authors:  B A Rasmussen; Y Gluzman; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3.

Authors:  J Schmid; E Voss; D R Soll
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 3.  Carbapenem-hydrolyzing beta-lactamases.

Authors:  B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

4.  Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II.

Authors:  J S Thompson; M H Malamy
Journal:  J Bacteriol       Date:  1990-05       Impact factor: 3.490

5.  Protein and carbohydrate moieties of a preparation of -lactamase II.

Authors:  S Kuwabara; P H Lloyd
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

6.  Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 beta-lactamase II structural gene.

Authors:  H M Lim; J J Pène; R W Shaw
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

7.  Properties of novel beta-lactamase produced by Bacteroides fragilis.

Authors:  A Yotsuji; S Minami; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

8.  Biochemical properties of beta-lactamase produced by Flavobacterium odoratum.

Authors:  K Sato; T Fujii; R Okamoto; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  Biochemical properties of beta-lactamase produced by Legionella gormanii.

Authors:  T Fujii; K Sato; K Miyata; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

10.  Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila.

Authors:  K Shannon; A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

View more
  39 in total

1.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Authors:  I C Materon; T Palzkill
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

3.  Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae.

Authors:  J J Yan; W C Ko; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an alcaligenes xylosoxidans strain.

Authors:  Shizuko Iyobe; Haruko Kusadokoro; Ayako Takahashi; Sachie Yomoda; Toyoji Okubo; Akio Nakamura; Koji O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Authors:  Samuel Bellais; Olivier Mimoz; Sophie Léotard; Anne Jacolot; Olivier Petitjean; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan.

Authors:  Hisakazu Yano; Miho Ogawa; Shiro Endo; Risako Kakuta; Hajime Kanamori; Shinya Inomata; Noriomi Ishibashi; Tetsuji Aoyagi; Masumitsu Hatta; Yoshiaki Gu; Mitsuhiro Yamada; Koichi Tokuda; Hiroyuki Kunishima; Miho Kitagawa; Yoichi Hirakata; Mitsuo Kaku
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

7.  Intra- and inter-species spread of carbapenemase genes in a non-hospitalized patient.

Authors:  L Sorlí; E Miró; C Segura; F Navarro; S Grau; M Salvado; J P Horcajada
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-14       Impact factor: 3.267

Review 8.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

9.  Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator.

Authors:  Susumu Tazuma; Yoshinori Igarashi; Toshio Tsuyuguchi; Hirotaka Ohara; Kazuo Inui; Toshihide Ohya
Journal:  J Gastroenterol       Date:  2009-05-23       Impact factor: 7.527

10.  Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.

Authors:  U Garza-Ramos; R Morfin-Otero; H S Sader; R N Jones; E Hernández; E Rodriguez-Noriega; A Sanchez; B Carrillo; S Esparza-Ahumada; J Silva-Sanchez
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.